
Join to view full profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Stewart is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California Davis HealthResidency, Ophthalmology, 1988 - 1989
Touro InfirmaryResidency, Ophthalmology, 1987 - 1988
Emory University School of MedicineResidency, Ophthalmology, 1984 - 1987
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1983 - 1984
McGill University Faculty of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1988 - Present
FL State Medical License 1989 - 2027
MN State Medical License 2014 - 2017
GA State Medical License 1984 - 1999
LA State Medical License 1987 - 1988
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Corporation, 2014-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- Incidence of Acute Cystoid Macular Edema After Penetrating Keratoplasty and Endothelial Keratoplasty.Ibrahim Qozat, Yazan Abubaker, Pranav Vasu, Isabella Wagner, Conner Lentz
Klinische Monatsblatter Fur Augenheilkunde. 2026-08-20 - Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice.Sobha Sivaprasad, Michael W Stewart, Charles C Wykoff, David Eichenbaum, Jean-Francois Korobelnik
Eye. 2026-08-07 - Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg: A 96-Week Pooled Analysis from PULSAR and PHOTON.Anat Loewenstein, Ursula Schmidt-Ott, Diana V Do, Paolo Lanzetta, Sergio Leal
Ophthalmology and Therapy. 2026-07-01
Press Mentions
Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD Meets Primary and Secondary EndpointsJuly 29th, 2019
Physicians' Perspective: Desired Changes Among Retina SpecialistsJuly 29th, 2019
Anti-VEGF Drugs Making a Difference in Vision, Longterm CareJanuary 28th, 2014
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








